scholarly journals Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists

2000 ◽  
Vol 84 (2) ◽  
pp. 181-185 ◽  
Author(s):  
J.-P. Nordmann
2007 ◽  
Vol 17 (5_suppl) ◽  
pp. 28-30 ◽  
Author(s):  
C. Migdal

Several fixed combination products are now available in glaucoma management. Considerations when selecting combination therapy include safety, finding the best combination of mechanisms of action. Combigan® is one such product that has been shown to be more effective than either of its constituent agents, brimonidine or timolol, used alone. It has at least a similar intraocular pressure (IOP)-lowering effect as the concomitant use of its two constituents, and it produces a significant additional lowering of IOP in patients who switch from other therapies, including Cosopt®. Combigan has high patient satisfaction ratings.


2014 ◽  
Vol 23 (5) ◽  
pp. 329-332 ◽  
Author(s):  
Tae-Woo Kim ◽  
Martha Kim ◽  
Eun Ji Lee ◽  
Jin Wook Jeoung ◽  
Ki Ho Park

2012 ◽  
Vol 28 (5) ◽  
pp. 524-528 ◽  
Author(s):  
Naveed Nilforushan ◽  
Ali Naghibi ◽  
Siamak Shokrollahi ◽  
Mostafa Soltan Sanjari ◽  
Kouros Nouri-Mahdavi

Sign in / Sign up

Export Citation Format

Share Document